Takanori Ueda
Overview
Explore the profile of Takanori Ueda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
203
Citations
1277
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsukasaki H, Fujita K, Lee S, Morishita T, Oiwa K, Negoro E, et al.
Ann Hematol
. 2024 Oct;
103(12):5549-5555.
PMID: 39453478
Despite an emphasis on the prognostic impact of serum soluble interleukin-2 receptor (sIL-2R) at diagnosis in patients with diffuse large B-cell lymphoma (DLBCL), whether the prognostic impact of elevated sIL-2R...
2.
Modha D, Akopyan F, Andreopoulos A, Appuswamy R, Arthur J, Cassidy A, et al.
Science
. 2023 Oct;
382(6668):329-335.
PMID: 37856600
Computing, since its inception, has been processor-centric, with memory separated from compute. Inspired by the organic brain and optimized for inorganic silicon, NorthPole is a neural inference architecture that blurs...
3.
Lee S, Fujita K, Morishita T, Negoro E, Tsukasaki H, Oiwa K, et al.
Cancers (Basel)
. 2023 Sep;
15(18).
PMID: 37760427
No studies have focused on the trajectory of the average relative dose intensity (ARDI) during cycles of first-line chemotherapy for patients with diffuse large B-cell lymphoma. To evaluate the impact...
4.
Oiwa K, Lee S, Fujita K, Ueda T, Yamauchi T
Intern Med
. 2023 Jul;
63(5):729-732.
PMID: 37468240
Most clonal cytogenetic abnormalities of Philadelphia-negative cells (CCA/Ph-) occurring during tyrosine kinase inhibitor (TKI) treatment are transient, and the development of secondary myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML) is rare,...
5.
Fujita K, Lee S, Morishita T, Negoro E, Oiwa K, Hara T, et al.
J Geriatr Oncol
. 2023 Jul;
14(7):101582.
PMID: 37429106
Introduction: As the numbers of older adult patients with acute myeloid leukemia (AML) continue to increase, the establishment of a simple geriatric assessment specifically for AML represents an unmet need....
6.
Oiwa K, Fujita K, Lee S, Morishita T, Tsujikawa T, Negoro E, et al.
Ann Hematol
. 2023 Mar;
102(5):1141-1148.
PMID: 36951966
Extranodal involvement predicts poor outcomes of diffuse large B cell lymphoma (DLBCL), but the impact of the metabolic tumor burden (MTV) of extranodal sites using positron emission tomography has not...
7.
Tsutani H, Otsuki N, Mitsuke Y, Ueda T
Mod Rheumatol
. 2022 Dec;
34(1):238-244.
PMID: 36478052
Objectives: Daily uric acid excretion (Eua) is an essential index for patients with gout/hyperuricaemia. We identified alternative indices most correlated with 24-hour uric acid clearance (Cua 24 h) and 24-hour...
8.
Itoh K, Shigemi H, Kinoshita K, Tsukasaki H, Imamura S, Morinaga K, et al.
Intern Med
. 2022 Mar;
61(20):3037-3044.
PMID: 35314551
Introduction Invasive fungal infections have been attracting attention as significant fatal complications in patients with febrile neutropenia (FN) who undergo intensive chemotherapy or hematopoietic stem cell transplantation to treat hematological...
9.
Lee S, Fujita K, Morishita T, Oiwa K, Tsukasaki H, Negoro E, et al.
Br J Haematol
. 2021 May;
194(2):325-335.
PMID: 34041751
Because of the heterogeneity among older patients with diffuse large B-cell lymphoma (DLBCL), the establishment of an easy-to-use geriatric assessment tool is an unmet need. We verified the impact of...
10.
Igarashi T, Kishi S, Hosono N, Higashi T, Iwao T, Yano R, et al.
Cancer Chemother Pharmacol
. 2021 Jan;
87(4):501-511.
PMID: 33416909
Purpose: Vincristine (VCR) is a key drug for treating various malignancies. However, few data are available on the pharmacokinetics of VCR, especially in adult patients. The objective of this study...